DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 0.00 0.00%
S&P 500 1,862.31 19.33 1.05%
market minute promo

NxStage Medical

NASDAQ: NXTM

12.34 0.30 (2.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NXTM $12.34 2.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.10
Previous Close $12.04
Daily Range $11.96 - $12.50
52-Week Range $8.77 - $15.00
Market Cap $755.2M
P/E Ratio -38.84
Dividend (Yield) $0.00 (0.0%)
Volume 732,084
Average Daily Volume 658,264
Current FY EPS -$0.41

Sector

Healthcare

Industry

Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website: http://www.nxstage.com/

News & Commentary Rss Feed

Is It Time to Buy These 4 Dialysis Stocks?

Should you consider buying these four dialysis stocks -- DaVita, Fresenius, NxStage, and Rockwell -- since the Centers for Medicare and Medicaid Services changed its tune on reducing payments to kidney dialysis providers?

NxStage Medical Breaks Below 200-Day Moving Average - Notable For NXTM

Commit To Buy NxStage Medical At $12.50, Earn 16.2% Annualized Using Options

Despite skepticism, market technicals remain bullish

NxStage Medical, Inc. Discusses Q4 2013 Results (Webcast)

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting End

Sector Update: Healthcare Shares Flat to Lower Pre-Market; Pacira Up 5% on Phase 3 Trial Meeting Endpoints

Sector Update: Healthcare

NxStage Medical (NXTM) Shares Cross Below 200 DMA

NxStage Medical CEO Presents at JPMorgan Healthcare Conference (Transcript)

3 Stocks Spiking on Big Volume

NxStage Gaining Ground On Growing Adoption Of Home Hemodialysis

See More NXTM News...

NXTM's Top Competitors

NXTM $12.34 (2.45%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $58.49 (0.76%)
Current stock: MDT
COV $69.84 (-0.09%)
Current stock: COV